 Prolonged indomethacin therapy prevention recurrences patent ductus arteriosus hypothesis maintenance indomethacin therapy effective closure patent ductus arteriosus PDA recurrence rate low birthweight neonates gm PDA double-blind fashion standard indomethacin therapy doses maintenance indomethacin therapy mg/kg/day days equivalent volume placebo days infants maintenance indomethacin therapy additional therapy required surgical ligation infants first indomethacin doses additional therapy PDA ligation maintenance indomethacin therapy comparison short-term indomethacin therapy incidence surgical PDA ligations PDA recurrences toxic effects indomethacin low birth infant PDA